This map shows the geographic impact of G L Scheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G L Scheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G L Scheffer more than expected).
This network shows the impact of papers produced by G L Scheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G L Scheffer. The network helps show where G L Scheffer may publish in the future.
Co-authorship network of co-authors of G L Scheffer
This figure shows the co-authorship network connecting the top 25 collaborators of G L Scheffer.
A scholar is included among the top collaborators of G L Scheffer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with G L Scheffer. G L Scheffer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Perego, Paola, Michelandrea De Cesare, Nives Carenini, et al.. (2001). A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.. PubMed. 61(16). 6034–7.73 indexed citations
5.
Erlichman, Charles, Scott A. Boerner, Xiaoxuan Wang, et al.. (2001). The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.. PubMed. 61(2). 739–48.174 indexed citations
6.
Scheffer, G L, Marc Maliepaard, Anouk B. Schroeijers, et al.. (2000). Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.. PubMed. 60(10). 2589–93.147 indexed citations
7.
Katsaros, D, Elisabeth G.E. de Vries, M Massobrio, et al.. (1999). Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.. PubMed. 5(10). 2798–805.91 indexed citations
8.
Schroeijers, Anouk B., G L Scheffer, M J Flens, et al.. (1998). Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.. PubMed. 152(2). 373–8.21 indexed citations
Schadendorf, Dirk, et al.. (1995). Membrane transport proteins associated with drug resistance expressed in human melanoma.. PubMed. 147(6). 1545–52.72 indexed citations
Slovak, ML, Susan P.C. Cole, Elisabeth G.E. de Vries, et al.. (1995). The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.. PubMed. 55(19). 4214–9.82 indexed citations
14.
Scheper, Rik J., H J Broxterman, G L Scheffer, et al.. (1993). Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.. PubMed. 53(7). 1475–9.433 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.